...
首页> 外文期刊>Pediatrics: Official Publication of the American Academy of Pediatrics >Clinical Features Affecting Final Adult Height in Patients With Pediatric-Onset Crohn's Disease
【24h】

Clinical Features Affecting Final Adult Height in Patients With Pediatric-Onset Crohn's Disease

机译:影响小儿克罗恩病患者最终成人身高的临床特征

获取原文
           

摘要

BACKGROUND. Growth failure is a recognized complication of pediatric-onset Crohn's disease, but there are few data on final adult height.OBJECTIVE. Our purpose with this work was to determine adult height and the clinical features that influence long-term growth impairment.METHODS. We retrospectively studied 123 patients with Crohn's disease (65 male and 58 female) who had reached adult height. All of the case subjects were diagnosed before age 16.0 years. Heights were converted to SD scores and univariate analysis performed of factors postulated to influence final height, that is, interval from onset of symptoms to diagnosis, prepubertal onset of symptoms, gender, jejunal disease present at diagnosis, systemic steroid therapy, intestinal surgery, and midparental height SD scores. Significant univariate factors were additional analyzed in regression models.RESULTS. Mean height deficit at diagnosis was ?0.50 SD scores, which improved to ?0.29 SD scores at final height. Mean final height compared with target height, calculated from parental height, was ?2.4 cm (range: ?20.0 to 9.0 cm). Nineteen percent of the case subjects achieved a final height 8.0 cm below target height. The length of the interval between symptom onset and diagnosis correlated negatively with height SD scores at diagnosis. Height SD scores at diagnosis were related to final height SD scores, independent of midparental height. The presence of jejunal disease was negatively related to final height.CONCLUSIONS. Mean final adult height showed a modest deficit compared with target height, but in one fifth of patients, final height was significantly less than target height. Earlier diagnosis and improved treatment of jejunal disease would be likely to improve final height.
机译:背景。生长衰竭是公认的小儿克罗恩病并发症,但有关最终成人身高的数据很少。我们这项工作的目的是确定成年人的身高以及影响长期生长损害的临床特征。我们回顾性研究了达到成人身高的123例克罗恩病患者(男65例,女58例)。所有病例均在16.0岁之前被诊断。将身高转换为SD评分,并对影响最终身高的因素进行单因素分析,即影响从症状发作到诊断的间隔,青春期前症状发作,性别,诊断时出现的空肠疾病,全身性类固醇治疗,肠外科手术和中父母身高SD分数。回归模型还对重要的单变量因素进行了分析。诊断时的平均身高不足为0.50 SD评分,而最终身高则为0.29 SD评分。由父母身高计算得出的平均最终身高与目标身高的比值约为2.4厘米(范围:20.0至9.0厘米)。 19%的案例受试者的最终身高比目标身高低8.0厘米。症状发作和诊断之间的时间间隔长度与诊断时的身高SD评分呈负相关。诊断时的身高SD评分与最终身高SD评分相关,而与父母中间身高无关。空肠疾病的存在与最终身高呈负相关。与目标身高相比,平均最终成人身高显示出适度的赤字,但在五分之一的患者中,最终身高明显低于目标身高。对空肠疾病的早期诊断和改良治疗可能会改善最终身高。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号